Ningpei Bai
Biographic Data
| ID | 8667040 |
|---|---|
| NAME | Ningpei Bai |
| GIVEN NAMES | Ningpei |
| FAMILY NAME | Bai |
| SIGNATURE | BAI N |
| AFFILIATIONS | Chongqing Academy of Environmental Science |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
HPV vaccination intention among guardians of male junior high school students in Chongqing, China
Background: The human papillomavirus (HPV) vaccine is essential for preventing sexually transmitted infections and HPV-related cancers in both men and women. Vaccinating boys directly protects them and contributes to herd immunity. It also indirectly protects their future partners. As parents' intentions strongly influence adolescents' HPV vaccination, this study aimed to investigate the factors that influence their vaccination intentions for son…
WSK-V102C Covid-19 vaccine effectiveness against Sars-CoV-2 JN.1 symptomatic infection among adults 60 years and older: A prospective observational cohort study in Shaanxi Province, China, 2024
Among individuals aged ≥ 60 years, WSK-V102C vaccination provided moderate protection against JN.1 symptomatic infection within 6 months, suggesting that older people can benefit from use of this vaccine
No prominent works on this page.
HPV vaccination intention among guardians of male junior high school students in Chongqing, China
Background: The human papillomavirus (HPV) vaccine is essential for preventing sexually transmitted infections and HPV-related cancers in both men and women. Vaccinating boys directly protects them and contributes to herd immunity. It also indirectly protects their future partners. As parents' intentions strongly influence adolescents' HPV vaccination, this study aimed to investigate the factors that influence their vaccination intentions for son…
WSK-V102C Covid-19 vaccine effectiveness against Sars-CoV-2 JN.1 symptomatic infection among adults 60 years and older: A prospective observational cohort study in Shaanxi Province, China, 2024
Among individuals aged ≥ 60 years, WSK-V102C vaccination provided moderate protection against JN.1 symptomatic infection within 6 months, suggesting that older people can benefit from use of this vaccine
Vaccination (2 works) · Biostatistics (1 works) · Cervical Cancer and HPV Research (1 works) · China (1 works) · Cohort study (1 works) · COVID-19 Clinical Research Studies (1 works) · Epidemiology (1 works) · Health care (1 works) · Health professionals (1 works) · HPV vaccines (1 works)